We've found
12,214
archived clinical trials in
Women's Studies
We've found
12,214
archived clinical trials in
Women's Studies
Starting Pediatric Obesity Prevention in Pregnancy
Updated: 12/31/1969
Starting Pediatric Obesity Prevention in Pregnancy
Status: Enrolling
Updated: 12/31/1969
Starting Pediatric Obesity Prevention in Pregnancy
Updated: 12/31/1969
Starting Pediatric Obesity Prevention in Pregnancy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic Malignancies
Updated: 12/31/1969
Impact of Intervention With Deferasirox on the Immune Function of Patients With Hematologic Diseases and Transfusion-Related Iron Overload
Status: Enrolling
Updated: 12/31/1969
Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic Malignancies
Updated: 12/31/1969
Impact of Intervention With Deferasirox on the Immune Function of Patients With Hematologic Diseases and Transfusion-Related Iron Overload
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Endoxifen in Adults With Hormone Receptor Positive Solid Tumors
Updated: 12/31/1969
Phase I Trial of Z-Endoxifen in Adults With Refractory Hormone Receptor-Positive Breast Cancer, Desmoid Tumors, Gynecologic Tumors, or Other Hormone Receptor-Positive Solid Tumors
Status: Enrolling
Updated: 12/31/1969
Endoxifen in Adults With Hormone Receptor Positive Solid Tumors
Updated: 12/31/1969
Phase I Trial of Z-Endoxifen in Adults With Refractory Hormone Receptor-Positive Breast Cancer, Desmoid Tumors, Gynecologic Tumors, or Other Hormone Receptor-Positive Solid Tumors
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Aging and Estrogen on Cortical Function
Updated: 12/31/1969
The Effect of Low Dose Estrogen on Cortical Function as a Function of Age in Postmenopausal Women.
Status: Enrolling
Updated: 12/31/1969
Aging and Estrogen on Cortical Function
Updated: 12/31/1969
The Effect of Low Dose Estrogen on Cortical Function as a Function of Age in Postmenopausal Women.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Changes in Sleep Patterns and Stress in Infants Entering Child Care
Updated: 12/31/1969
Changes in Sleep Patterns and Stress in Infants Entering Child Care: Implications for SIDS Risk
Status: Enrolling
Updated: 12/31/1969
Changes in Sleep Patterns and Stress in Infants Entering Child Care
Updated: 12/31/1969
Changes in Sleep Patterns and Stress in Infants Entering Child Care: Implications for SIDS Risk
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Pilot Study of a Catheter-based Ultrasound Hyperthermia System
Updated: 12/31/1969
Pilot Study of a Catheter-based Ultrasound Hyperthermia System
Status: Enrolling
Updated: 12/31/1969
Pilot Study of a Catheter-based Ultrasound Hyperthermia System
Updated: 12/31/1969
Pilot Study of a Catheter-based Ultrasound Hyperthermia System
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Targeted Phase I/II Trial of ZD6474 (Vandetanib; ZACTIMA) Plus the Proteasome Inhibitor, Bortezomib (Velcade ), in Adults With Solid Tumors With a Focus on Hereditary or Sporadic, Locally Advanced or Metastatic Medullary Thyroid Cancer (MTC)
Updated: 12/31/1969
A Targeted Ph I/II Trial of ZD6474 (Vandetanib; CAPRELSA) Plus the Proteasome Inhibitor, Bortezomib (Velcade ), in Adults With Solid Tumors With a Focus on Hereditary or Sporadic, Locally Advanced or Metastatic Medullary Thyroid Ca (MTC)
Status: Enrolling
Updated: 12/31/1969
A Targeted Phase I/II Trial of ZD6474 (Vandetanib; ZACTIMA) Plus the Proteasome Inhibitor, Bortezomib (Velcade ), in Adults With Solid Tumors With a Focus on Hereditary or Sporadic, Locally Advanced or Metastatic Medullary Thyroid Cancer (MTC)
Updated: 12/31/1969
A Targeted Ph I/II Trial of ZD6474 (Vandetanib; CAPRELSA) Plus the Proteasome Inhibitor, Bortezomib (Velcade ), in Adults With Solid Tumors With a Focus on Hereditary or Sporadic, Locally Advanced or Metastatic Medullary Thyroid Ca (MTC)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study to Describe the Pharmacokinetics of Acyclovir in Premature Infants (PTN_Acyclo)
Updated: 12/31/1969
An Open Label Study to Describe the Pharmacokinetics of Acyclovir in Premature Infants
Status: Enrolling
Updated: 12/31/1969
A Study to Describe the Pharmacokinetics of Acyclovir in Premature Infants (PTN_Acyclo)
Updated: 12/31/1969
An Open Label Study to Describe the Pharmacokinetics of Acyclovir in Premature Infants
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study to Describe the Pharmacokinetics of Acyclovir in Premature Infants (PTN_Acyclo)
Updated: 12/31/1969
An Open Label Study to Describe the Pharmacokinetics of Acyclovir in Premature Infants
Status: Enrolling
Updated: 12/31/1969
A Study to Describe the Pharmacokinetics of Acyclovir in Premature Infants (PTN_Acyclo)
Updated: 12/31/1969
An Open Label Study to Describe the Pharmacokinetics of Acyclovir in Premature Infants
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study to Describe the Pharmacokinetics of Acyclovir in Premature Infants (PTN_Acyclo)
Updated: 12/31/1969
An Open Label Study to Describe the Pharmacokinetics of Acyclovir in Premature Infants
Status: Enrolling
Updated: 12/31/1969
A Study to Describe the Pharmacokinetics of Acyclovir in Premature Infants (PTN_Acyclo)
Updated: 12/31/1969
An Open Label Study to Describe the Pharmacokinetics of Acyclovir in Premature Infants
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Effect of Cinnamon Extract on Insulin Resistance in Polycystic Ovary Syndrome
Updated: 12/31/1969
Phase 1 Study That Will Compare 12 Weeks of Supplementation With Cinnamon Extract on the Action of Insulin and Blood Sugar (Glucose) With 12 Weeks of Supplementation With a Placebo.
Status: Enrolling
Updated: 12/31/1969
Effect of Cinnamon Extract on Insulin Resistance in Polycystic Ovary Syndrome
Updated: 12/31/1969
Phase 1 Study That Will Compare 12 Weeks of Supplementation With Cinnamon Extract on the Action of Insulin and Blood Sugar (Glucose) With 12 Weeks of Supplementation With a Placebo.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Therapeutic Vaccination for Patients With HPV16+ Cervical Intraepithelial Neoplasia (CIN2/3)
Updated: 12/31/1969
A Pilot Study of pnGVL4a-CRT/E7 (Detox) for the Treatment of Patients With HPV16+ Cervical Intraepithelial Neoplasia 2/3 (CIN2/3)
Status: Enrolling
Updated: 12/31/1969
Therapeutic Vaccination for Patients With HPV16+ Cervical Intraepithelial Neoplasia (CIN2/3)
Updated: 12/31/1969
A Pilot Study of pnGVL4a-CRT/E7 (Detox) for the Treatment of Patients With HPV16+ Cervical Intraepithelial Neoplasia 2/3 (CIN2/3)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Therapeutic Vaccination for Patients With HPV16+ Cervical Intraepithelial Neoplasia (CIN2/3)
Updated: 12/31/1969
A Pilot Study of pnGVL4a-CRT/E7 (Detox) for the Treatment of Patients With HPV16+ Cervical Intraepithelial Neoplasia 2/3 (CIN2/3)
Status: Enrolling
Updated: 12/31/1969
Therapeutic Vaccination for Patients With HPV16+ Cervical Intraepithelial Neoplasia (CIN2/3)
Updated: 12/31/1969
A Pilot Study of pnGVL4a-CRT/E7 (Detox) for the Treatment of Patients With HPV16+ Cervical Intraepithelial Neoplasia 2/3 (CIN2/3)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Therapeutic Vaccination for Patients With HPV16+ Cervical Intraepithelial Neoplasia (CIN2/3)
Updated: 12/31/1969
A Pilot Study of pnGVL4a-CRT/E7 (Detox) for the Treatment of Patients With HPV16+ Cervical Intraepithelial Neoplasia 2/3 (CIN2/3)
Status: Enrolling
Updated: 12/31/1969
Therapeutic Vaccination for Patients With HPV16+ Cervical Intraepithelial Neoplasia (CIN2/3)
Updated: 12/31/1969
A Pilot Study of pnGVL4a-CRT/E7 (Detox) for the Treatment of Patients With HPV16+ Cervical Intraepithelial Neoplasia 2/3 (CIN2/3)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Mechanisms of Increased Androgen Production Among Women With Polycystic Ovary Syndrome
Updated: 12/31/1969
Mechanisms of Increased Androgen Production Among Women With Polycystic Ovary Syndrome
Status: Enrolling
Updated: 12/31/1969
Mechanisms of Increased Androgen Production Among Women With Polycystic Ovary Syndrome
Updated: 12/31/1969
Mechanisms of Increased Androgen Production Among Women With Polycystic Ovary Syndrome
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Comparative Effects of Nebivolol and Metoprolol on Female Sexual Function
Updated: 12/31/1969
Comparative Effects of Nebivolol and Metoprolol on Female Sexual Function
Status: Enrolling
Updated: 12/31/1969
Comparative Effects of Nebivolol and Metoprolol on Female Sexual Function
Updated: 12/31/1969
Comparative Effects of Nebivolol and Metoprolol on Female Sexual Function
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies
Updated: 12/31/1969
Nonmyeloablative Hematopoietic Cell Transplantation (HCT) for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors: A Phase II Trial of Peripheral Blood Stem Cells (PBSC) as the Donor Source
Status: Enrolling
Updated: 12/31/1969
Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies
Updated: 12/31/1969
Nonmyeloablative Hematopoietic Cell Transplantation (HCT) for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors: A Phase II Trial of Peripheral Blood Stem Cells (PBSC) as the Donor Source
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies
Updated: 12/31/1969
Nonmyeloablative Hematopoietic Cell Transplantation (HCT) for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors: A Phase II Trial of Peripheral Blood Stem Cells (PBSC) as the Donor Source
Status: Enrolling
Updated: 12/31/1969
Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies
Updated: 12/31/1969
Nonmyeloablative Hematopoietic Cell Transplantation (HCT) for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors: A Phase II Trial of Peripheral Blood Stem Cells (PBSC) as the Donor Source
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis
Updated: 12/31/1969
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Immunogenicity of Off-Schedule Dosing of HPV Vaccine
Updated: 12/31/1969
Immunogenicity of the HPV-6, 11, 16, 18 Vaccine Among Adolescent Girls Who Receive Vaccine Doses at Non-recommended Intervals and Factors Related to Non-adherence
Status: Enrolling
Updated: 12/31/1969
Immunogenicity of Off-Schedule Dosing of HPV Vaccine
Updated: 12/31/1969
Immunogenicity of the HPV-6, 11, 16, 18 Vaccine Among Adolescent Girls Who Receive Vaccine Doses at Non-recommended Intervals and Factors Related to Non-adherence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Immunogenicity of Off-Schedule Dosing of HPV Vaccine
Updated: 12/31/1969
Immunogenicity of the HPV-6, 11, 16, 18 Vaccine Among Adolescent Girls Who Receive Vaccine Doses at Non-recommended Intervals and Factors Related to Non-adherence
Status: Enrolling
Updated: 12/31/1969
Immunogenicity of Off-Schedule Dosing of HPV Vaccine
Updated: 12/31/1969
Immunogenicity of the HPV-6, 11, 16, 18 Vaccine Among Adolescent Girls Who Receive Vaccine Doses at Non-recommended Intervals and Factors Related to Non-adherence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Immunogenicity of Off-Schedule Dosing of HPV Vaccine
Updated: 12/31/1969
Immunogenicity of the HPV-6, 11, 16, 18 Vaccine Among Adolescent Girls Who Receive Vaccine Doses at Non-recommended Intervals and Factors Related to Non-adherence
Status: Enrolling
Updated: 12/31/1969
Immunogenicity of Off-Schedule Dosing of HPV Vaccine
Updated: 12/31/1969
Immunogenicity of the HPV-6, 11, 16, 18 Vaccine Among Adolescent Girls Who Receive Vaccine Doses at Non-recommended Intervals and Factors Related to Non-adherence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Immunogenicity of Off-Schedule Dosing of HPV Vaccine
Updated: 12/31/1969
Immunogenicity of the HPV-6, 11, 16, 18 Vaccine Among Adolescent Girls Who Receive Vaccine Doses at Non-recommended Intervals and Factors Related to Non-adherence
Status: Enrolling
Updated: 12/31/1969
Immunogenicity of Off-Schedule Dosing of HPV Vaccine
Updated: 12/31/1969
Immunogenicity of the HPV-6, 11, 16, 18 Vaccine Among Adolescent Girls Who Receive Vaccine Doses at Non-recommended Intervals and Factors Related to Non-adherence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Immunogenicity of Off-Schedule Dosing of HPV Vaccine
Updated: 12/31/1969
Immunogenicity of the HPV-6, 11, 16, 18 Vaccine Among Adolescent Girls Who Receive Vaccine Doses at Non-recommended Intervals and Factors Related to Non-adherence
Status: Enrolling
Updated: 12/31/1969
Immunogenicity of Off-Schedule Dosing of HPV Vaccine
Updated: 12/31/1969
Immunogenicity of the HPV-6, 11, 16, 18 Vaccine Among Adolescent Girls Who Receive Vaccine Doses at Non-recommended Intervals and Factors Related to Non-adherence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Immunogenicity of Off-Schedule Dosing of HPV Vaccine
Updated: 12/31/1969
Immunogenicity of the HPV-6, 11, 16, 18 Vaccine Among Adolescent Girls Who Receive Vaccine Doses at Non-recommended Intervals and Factors Related to Non-adherence
Status: Enrolling
Updated: 12/31/1969
Immunogenicity of Off-Schedule Dosing of HPV Vaccine
Updated: 12/31/1969
Immunogenicity of the HPV-6, 11, 16, 18 Vaccine Among Adolescent Girls Who Receive Vaccine Doses at Non-recommended Intervals and Factors Related to Non-adherence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Immunogenicity of Off-Schedule Dosing of HPV Vaccine
Updated: 12/31/1969
Immunogenicity of the HPV-6, 11, 16, 18 Vaccine Among Adolescent Girls Who Receive Vaccine Doses at Non-recommended Intervals and Factors Related to Non-adherence
Status: Enrolling
Updated: 12/31/1969
Immunogenicity of Off-Schedule Dosing of HPV Vaccine
Updated: 12/31/1969
Immunogenicity of the HPV-6, 11, 16, 18 Vaccine Among Adolescent Girls Who Receive Vaccine Doses at Non-recommended Intervals and Factors Related to Non-adherence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Multi-dose Pharmacokinetics and Dose Ranging of Inositol in Premature Infants (INS-2)
Updated: 12/31/1969
Phase II Randomized, Double-Masked, Placebo-Controlled, Safety, Pharmacokinetic, and Dose-Ranging Study of Multiple Doses of Inositol in Premature Infants
Status: Enrolling
Updated: 12/31/1969
Multi-dose Pharmacokinetics and Dose Ranging of Inositol in Premature Infants (INS-2)
Updated: 12/31/1969
Phase II Randomized, Double-Masked, Placebo-Controlled, Safety, Pharmacokinetic, and Dose-Ranging Study of Multiple Doses of Inositol in Premature Infants
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Multi-dose Pharmacokinetics and Dose Ranging of Inositol in Premature Infants (INS-2)
Updated: 12/31/1969
Phase II Randomized, Double-Masked, Placebo-Controlled, Safety, Pharmacokinetic, and Dose-Ranging Study of Multiple Doses of Inositol in Premature Infants
Status: Enrolling
Updated: 12/31/1969
Multi-dose Pharmacokinetics and Dose Ranging of Inositol in Premature Infants (INS-2)
Updated: 12/31/1969
Phase II Randomized, Double-Masked, Placebo-Controlled, Safety, Pharmacokinetic, and Dose-Ranging Study of Multiple Doses of Inositol in Premature Infants
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Multi-dose Pharmacokinetics and Dose Ranging of Inositol in Premature Infants (INS-2)
Updated: 12/31/1969
Phase II Randomized, Double-Masked, Placebo-Controlled, Safety, Pharmacokinetic, and Dose-Ranging Study of Multiple Doses of Inositol in Premature Infants
Status: Enrolling
Updated: 12/31/1969
Multi-dose Pharmacokinetics and Dose Ranging of Inositol in Premature Infants (INS-2)
Updated: 12/31/1969
Phase II Randomized, Double-Masked, Placebo-Controlled, Safety, Pharmacokinetic, and Dose-Ranging Study of Multiple Doses of Inositol in Premature Infants
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials